Of interest, a very recent study revealed that sEV PD-L1 in melanoma patients were secreted by both tumor cells and immune cells, and only tumor cell- and CD8 T cell-derived PD-L1-positve sEVs were significantly higher in non-responders than in responders41. This evidence concerns the gene CD274 and melanoma.